Binding of plasminogen activator inhibitor type-1 to extracellular matrix of Hep G2 cells.
Open Access
- 1 March 1991
- journal article
- abstracts
- Published by Elsevier BV
- Vol. 266 (7), 4334-4340
- https://doi.org/10.1016/s0021-9258(20)64327-7
Abstract
Catabolism of plasminogen activators by Hep G2 cells is mediated by a specific receptor which recognizes complexes of these serine proteases with their physiological inhibitor, plasminogen activator inhibitor type-1 (PAI-1). This catabolic process is initiated by interaction of exogenous plasminogen activators with bioactive PAI-1, which is secreted and localizes in an active form to the extracellular matrix (ECM) of Hep G2 cells. We now report that vitronectin (VN) mediates the specific binding of PAI-1 to the ECM of these cells. Purified bovine or human VN competes for specific binding of PAI-1 to Hep G2 ECM, and ligand blotting reveals specific binding of PAI-1 to ECM-associated VN. Hep G2 cells secrete both VN and PAI-1, and pulse-chase studies strongly suggest that these proteins associate only following secretion. Although Hep G2 cell-derived VN does not significantly bind to ECM in vitro, 30-40% of endogenous PAI-1 binds to the ECM, even in the presence of human serum, suggesting that ECM-associated VN is entirely derived from bovine serum. PAI-1 was localized by indirect immunofluorescence to ECM beneath cells and at cell margins, whereas VN exhibited a uniform distribution throughout the growth substratum. VN associated with the ECM may confer retention and bioactivity to PAI-1, potentially facilitating both pericellular regulation of plasmin generation and the rapid hepatic clearance of plasminogen activators.Keywords
This publication has 35 references indexed in Scilit:
- Bovine plasminogen activator inhibitor 1: Specificity determinations and comparison of the active, latent, and guanidine-activated formsBiochemistry, 1988
- Plasminogen activator inhibitor is associated with the extracellular matrix of cultured bovine smooth muscle cells.JCI Insight, 1987
- Rapid inactivation of the plasminogen-activator inhibitor upon secretion from cultured human endothelial cellsBiochemical Journal, 1986
- Human spreading factor: Synthesis and response by HepG2 hepatoma cells in cultureJournal of Cellular Physiology, 1985
- Vitronectin—A major cell attachment-promoting protein in fetal bovine serumExperimental Cell Research, 1985
- Generation in plasma of a fast-acting inhibitor of plasminogen activator in response to endotoxin stimulation.JCI Insight, 1985
- Detection of antigens on nitrocellulose paper immunoblots with monoclonal antibodiesAnalytical Biochemistry, 1983
- Serum spreading factor (vitronectin) is present at the cell surface and in tissues.Proceedings of the National Academy of Sciences of the United States of America, 1983
- Human Hepatocellular Carcinoma Cell Lines Secrete the Major Plasma Proteins and Hepatitis B Surface AntigenScience, 1980
- Protein and cell membrane iodinations with a sparingly soluble chloroamide, 1,3,4,6-tetrachloro-3a,6a-diphenylglycolurilBiochemical and Biophysical Research Communications, 1978